国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Industries

Med-tech MNCs see healthy market space

China Daily | Updated: 2022-11-11 09:38
Share
Share - WeChat
Bian Xin, CEO of Roche Pharmaceuticals China

A1 In the past five years, the CIIE has become a very important stage for the debut of global innovative products and cutting-edge technologies, and it has also built an excellent platform for communications and exchanges between the government and enterprises, and between enterprises.

The 20th National Congress of the Communist Party of China just closed. We believe the opening of the fifth CIIE at this point fully demonstrates the country's commitment to achieving high-quality economic development and its new strides in reform and opening-up.

We believe that the convening of the CIIE will provide more "Chinese opportunities" for the rest of the world. Roche is encouraged, with stronger confidence in and commitment to the Chinese market.

A2 It's a great honor for Roche to attend the CIIE for five consecutive years. With one of the largest booth areas in the medical and healthcare pavilion, Roche highlights a full portfolio of launched and market-ready products at its 1,000-square-meter booth, including nearly 10 global innovative products that will soon be launched in China, covering major disease areas such as hematological tumors, breast cancer, ophthalmology and neuroscience.

At the expo, Roche holistically showcases multiple innovative projects and solutions. We hope to leverage the CIIE as a bridge to align with the Chinese government and partners in enhancing exchange and collaboration, seeking synergies in resources to foster industry development, and jointly building, creating and sharing the healthcare ecosystem in China.

A3 In recent years, we have seen that China has further deepened reform, which has unleashed more market vitality and economic resilience. Recently, a series of policies have been introduced to help increase, stabilize and improve the quality of foreign investment. We firmly believe that these positive measures will further boost our confidence in continuing to deepen our business in China, increase our business in China and invest in China.

A4 China has become the world's second-largest pharmaceutical market. Global companies like Roche have benefited from the country's opening-up and economic reform, which has led to a favorable business environment and easier market access.

In the healthcare sector, we have seen significant improvements in policies and measures to accelerate the regulatory approval and affordability of innovative drugs in recent years, to promote the transformation and upgrading of the industry and the high-quality development of the economy and society. We are also heartened to see that the government places a strategic priority on ensuring people's health and improving policies for promoting public health, which shows the government's commitment to elevating the health and well-being of the Chinese people.

|<< Previous 1 2 3 4 5 6 7 Next   >>|
Top
BACK TO THE TOP
English
Copyright 1994 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
吉木萨尔县| 彭山县| 涪陵区| 林芝县| 赫章县| 奉节县| 龙口市| 文水县| 石河子市| 民乐县| 通山县| 安乡县| 林口县| 渭源县| 揭阳市| 柳河县| 鄯善县| 冕宁县| 闵行区| 图木舒克市| 荃湾区| 景德镇市| 元江| 十堰市| 定州市| 新野县| 泽库县| 武穴市| 高陵县| 宁明县| 丰县| 定边县| 泌阳县| 维西| 阜阳市| 岚皋县| 勃利县| 岑溪市| 怀宁县| 黔西县| 沧源|